Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05403736 · ClinicalTrials.gov registry record · NA
Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
A NA study of Cancer, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05403736 is a NA study of Cancer that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 20 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05403736, a NA study of Cancer, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine adherence to cardio-oncology consultation.
Conditions Studied
Interventions
- OTHER Cardiac Aggressive Risk MitigAtion Plan
Study Locations (1)
California
- Cancer Clinical Trials Office - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-10-07 |
| Est. Completion | 2023-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05403736
The ClinicalTrials.gov registry entry for NCT05403736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Aggressive Risk MitigAtion Plan is the first listed.
NCT05403736 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05403736 about?
NCT05403736 is a clinical study titled "Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial". The purpose of this study is to examine adherence to cardio-oncology consultation.
What is the current status of trial NCT05403736?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-10-07. Estimated completion is 2023-06-16.
What conditions does trial NCT05403736 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05403736?
The interventions under investigation include: Cardiac Aggressive Risk MitigAtion Plan (OTHER).
Who is sponsoring clinical trial NCT05403736?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05403736 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.